Free Trial
NASDAQ:LFMD

LifeMD (LFMD) Stock Price, News & Analysis

LifeMD logo
$5.04 +0.14 (+2.86%)
(As of 12/20/2024 05:16 PM ET)

About LifeMD Stock (NASDAQ:LFMD)

Key Stats

Today's Range
$4.76
$5.17
50-Day Range
$4.08
$7.16
52-Week Range
$3.99
$12.88
Volume
1.33 million shs
Average Volume
742,021 shs
Market Capitalization
$218.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.57
Consensus Rating
Moderate Buy

Company Overview

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LifeMD Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
28th Percentile Overall Score

LFMD MarketRank™: 

LifeMD scored higher than 28% of companies evaluated by MarketBeat, and ranked 810th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeMD has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    LifeMD has only been the subject of 3 research reports in the past 90 days.

  • Read more about LifeMD's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeMD are expected to grow in the coming year, from ($0.56) to $0.12 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeMD is -7.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeMD is -7.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    LifeMD has a P/B Ratio of 33.60. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    17.72% of the float of LifeMD has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeMD has a short interest ratio ("days to cover") of 9.9.
  • Change versus previous month

    Short interest in LifeMD has recently increased by 1.70%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    LifeMD does not currently pay a dividend.

  • Dividend Growth

    LifeMD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    17.72% of the float of LifeMD has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeMD has a short interest ratio ("days to cover") of 9.9.
  • Change versus previous month

    Short interest in LifeMD has recently increased by 1.70%, indicating that investor sentiment is decreasing.
  • Search Interest

    19 people have searched for LFMD on MarketBeat in the last 30 days. This is an increase of 73% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added LifeMD to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeMD insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $163,000.00 in company stock.

  • Percentage Held by Insiders

    15.97% of the stock of LifeMD is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 35.52% of the stock of LifeMD is held by institutions.

  • Read more about LifeMD's insider trading history.
Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

LFMD Stock News Headlines

Why I'm telling friends to avoid gold stocks
Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."
LifeMD initiated with a Neutral at Mizuho
LifeMD (LFMD) Gets a Buy from Craig-Hallum
LifeMD to Participate in Three Investor Conferences During November
LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results
See More Headlines

LFMD Stock Analysis - Frequently Asked Questions

LifeMD's stock was trading at $8.29 at the beginning of 2024. Since then, LFMD stock has decreased by 39.2% and is now trading at $5.04.
View the best growth stocks for 2024 here
.

LifeMD, Inc. (NASDAQ:LFMD) released its earnings results on Wednesday, August, 7th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by $0.06. The business earned $50.66 million during the quarter, compared to the consensus estimate of $48.47 million.

LifeMD's top institutional shareholders include State Street Corp (2.67%), Royce & Associates LP (2.09%), Geode Capital Management LLC (1.89%) and Connor Clark & Lunn Investment Management Ltd. (1.78%). Insiders that own company stock include Justin Schreiber, Bertrand Velge, Naveen Bhatia, Nicholas P Alvarez, Eric Harold Yecies, Stefan Galluppi and Joseph Ditrolio.
View institutional ownership trends
.

Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeMD investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF), Adobe (ADBE) and Jabil (JBL).

Company Calendar

Last Earnings
8/07/2024
Today
12/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
Healthcare
Current Symbol
NASDAQ:LFMD
Fax
N/A
Employees
230
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.57
High Stock Price Target
$15.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+129.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$-20,600,000.00
Pretax Margin
-11.15%

Debt

Sales & Book Value

Annual Sales
$193.06 million
Book Value
$0.15 per share

Miscellaneous

Free Float
36,395,000
Market Cap
$218.29 million
Optionable
Optionable
Beta
1.38
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (NASDAQ:LFMD) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners